2020
DOI: 10.1007/s40618-020-01299-1
|View full text |Cite
|
Sign up to set email alerts
|

Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
45
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 51 publications
(48 citation statements)
references
References 65 publications
3
45
0
Order By: Relevance
“…Testosterone replacement therapy outcomes observed in KS patients are similar to those reported in males with hypogonadism unrelated to KS [15]. In particular, body composition and bone mineral density appear better in treated than untreated hypogonadal KS patients [18].…”
Section: Discussionsupporting
confidence: 68%
See 1 more Smart Citation
“…Testosterone replacement therapy outcomes observed in KS patients are similar to those reported in males with hypogonadism unrelated to KS [15]. In particular, body composition and bone mineral density appear better in treated than untreated hypogonadal KS patients [18].…”
Section: Discussionsupporting
confidence: 68%
“…Treatment of KS aims to decrease symptoms, enhance functionality, and improve the wellbeing of patients and their family environment, as likewise occurs in most chronic disorders. Testosterone replacement therapy, which is the accepted standard of care in KS patients, indeed, produces no effect on infertility caused by the disease, but corrects the androgen deficiency, and provides patients with appropriate virilization (improved libido, sexual activity, nocturnal erections, sexual thoughts, and sexual satisfaction), considerable increased skeletal muscle strength and hematocrit, plus reduced bone resorption [16][17][18].…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, testosterone treatment in hypogonadal men with KS improved body composition and BMD at the spinal level. The effects on lipid and glucose profile were less significant evident 129 . Larger and longer placebo‐controlled RCT is necessary however to fully understand the benefits of testosterone treatment in KS.…”
Section: Clinical Pictures Diagnostic Steps and Therapymentioning
confidence: 95%
“…However, the latter cannot entirely explain the increased CV risk and other factors (such as epigenetic mechanisms and AR functionality) are most likely involved 4,6,9,142 . Accordingly, testosterone replacement therapy does not completely attenuate the increased cardiometabolic risk 129 …”
Section: Clinical Pictures Diagnostic Steps and Therapymentioning
confidence: 98%
See 1 more Smart Citation